Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Orthosera GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11270
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of new disease areas and to advance development of pipeline products in orthopedic, dental and spine applications. OrthoSera also offers BoneAlbumin and hyper acute serum. The company’s BoneAlbumin is a bone void filler used in dentistry and orthopaedics. It conducts research on bone grafting, wound healing, osteoarthritis, and dental and orthopedic indications. OrthoSera is headquartered in Krems an der Donau, Austria.

Orthosera GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orthosera GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
OrthoSera Raises Funds through Series B Financing 11
OrthoSera Raises Funds in Financing Round 12
Lacerta Technologies Raises Funds Through Seed Financing 13
Orthosera GmbH – Key Competitors 14
Orthosera GmbH – Key Employees 15
Orthosera GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Orthosera GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OrthoSera Raises Funds through Series B Financing 11
OrthoSera Raises Funds in Financing Round 12
Lacerta Technologies Raises Funds Through Seed Financing 13
Orthosera GmbH, Key Competitors 14
Orthosera GmbH, Key Employees 15

List of Figures
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bando Chemical Industries, Ltd. (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries, Ltd. (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Mankind Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mankind Pharma Ltd (MPL) is a manufacturer and supplier of prescriptions medicines, over-the-counter and FMCG products. The company offers prescription medicines in dosage forms of oral solids, oral liquids, soft gelatine capsules and injectables. Its products are used in therapeutic areas o …
  • Intellicheck, Inc. (IDN):企業の財務・戦略的SWOT分析
    Intellicheck, Inc. (IDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rackspace Hosting, Inc.:企業の戦略・SWOT・財務情報
    Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Franklin Resources, Inc.:企業のM&A・事業提携・投資動向
    Franklin Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Franklin Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Stifel Financial Corp.:企業のM&A・事業提携・投資動向
    Stifel Financial Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stifel Financial Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Eurus Energy Holdings Corp:電力:M&Aディール及び事業提携情報
    Summary Eurus Energy Holdings Corp (Eurus Energy), a subsidiary of Toyota Tsusho Corporation, is a renewable energy company that generates power through various renewable sources such as wind and solar photovoltaic. The company's services include location survey, wind or sunlight study, basic design …
  • Becton Dickinson and Co (BDX)-製薬・医療分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • Liberty Oilfield Services Inc (LBRT):企業の財務・戦略的SWOT分析
    Liberty Oilfield Services Inc (LBRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Macy’s Inc:企業の戦略・SWOT・財務情報
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Microsemi Corporation:企業の戦略・SWOT・財務情報
    Microsemi Corporation - Strategy, SWOT and Corporate Finance Report Summary Microsemi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • viDA Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary viDA Therapeutics Inc (viDA) is a biopharmaceutical company that discovers, develops and commercializes novel and targeted therapeutics for the treatment of autoimmune and age-related chronic inflammatory diseases. The company’s lead product candidate include VTI-1002, is in a topical formul …
  • Andalay Solar Inc (WEST):企業の財務・戦略的SWOT分析
    Andalay Solar Inc (WEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Beckman Coulter, Inc.:企業の戦略・SWOT・財務情報
    Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …
  • Motif BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motif BioSciences Inc (Motif), a subsidiary of Motif Bio Plc is a clinical stage biopharmaceutical company that manufactures novel antibiotics designed to treat life-threatening infections caused by multi-drug resistant bacteria. The company’s product programs include MTF-001, iclaprim, and …
  • Sumitomo Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Dar Al Dawa Development & Investment Co Ltd (DADI):企業の財務・戦略的SWOT分析
    Dar Al Dawa Development & Investment Co Ltd (DADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆